Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine.
about
Targeted therapy for soft tissue sarcomas in adolescents and young adults.Aspects of Tryptophan and Nicotinamide Adenine Dinucleotide in Immunity: A New Twist in an Old TaleStrategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma.NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
P2860
Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Diversification of Antitumour ...... lenced Dendritic Cell Vaccine.
@en
Diversification of Antitumour ...... lenced Dendritic Cell Vaccine.
@nl
type
label
Diversification of Antitumour ...... lenced Dendritic Cell Vaccine.
@en
Diversification of Antitumour ...... lenced Dendritic Cell Vaccine.
@nl
prefLabel
Diversification of Antitumour ...... lenced Dendritic Cell Vaccine.
@en
Diversification of Antitumour ...... lenced Dendritic Cell Vaccine.
@nl
P2093
P2860
P356
P1476
Diversification of Antitumour ...... lenced Dendritic Cell Vaccine.
@en
P2093
Anne Mobergslien
Gunnar Kvalheim
Marta Nyakas
Stein Sæbøe-Larssen
Steinar Aamdal
P2860
P304
P356
10.1155/2016/9639585
P50
P577
2016-07-18T00:00:00Z